Cardiovascular death in rheumatoid arthritis: a population-based study

Area of Science:

• Rheumatology
• Cardiovascular Medicine
• Epidemiology

Background:

• Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease.
• Traditional cardiovascular risk factors may not fully explain the excess cardiovascular mortality in RA patients.

Purpose of the Study:

• To investigate if systemic inflammation provides an additional risk for cardiovascular death in rheumatoid arthritis patients.
• To adjust for established cardiovascular risk factors and comorbidities in this analysis.

Main Methods:

• An incidence cohort of 603 rheumatoid arthritis patients was established from population-based data.
• Patients were followed longitudinally for mortality, with detailed data on cardiovascular risk factors, inflammation markers (e.g., ESR), and comorbidities.
• Cox regression models were used to identify predictors of cardiovascular death.

Main Results:

• Cardiovascular disease was the primary cause of death in 176 out of 354 deaths during a mean follow-up of 15 years.
• Traditional risk factors (smoking, hypertension, diabetes) and comorbidities were significant predictors of cardiovascular death.
• Elevated erythrocyte sedimentation rate (ESR) values (≥60 mm/hour), RA vasculitis, and RA lung disease were associated with a significantly higher risk of cardiovascular death (HRs ranging from 2.03 to 2.41).

Conclusions:

• Markers of systemic inflammation confer a statistically significant additional risk for cardiovascular death in rheumatoid arthritis patients.
• These findings persist even after controlling for traditional cardiovascular risk factors and comorbidities.
• Managing systemic inflammation may be crucial for reducing cardiovascular mortality in RA.